conducted mass spectrometry and validated constitutive serum amyloid A4 (SAA4), gelsolin (GSN), and vitamin D-binding protein (VDPR) as RA biomarkers, which has value for not only the diagnosis but also the prevention and treatment of rheumatic diseases (65). The gene discussed is GSN; the disease is rheumatic disorder.